Daré Bioscience Inc. (DARE)
NASDAQ: DARE
· Real-Time Price · USD
2.89
0.01 (0.35%)
At close: May 30, 2025, 3:57 PM
2.75
-4.84%
Pre-market: Jun 02, 2025, 08:07 AM EDT
Daré Bioscience Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 |
|---|---|---|
| License And Collaboration Revenues Revenue | 11M | 10M |
| License And Collaboration Revenues Revenue Growth | +10.00% | n/a |
| Royalty Revenue Revenue | 18K | n/a |
| Royalty Revenue Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.31M | 1.92M | 2.04M | 2.47M | 2.66M | 3.14M | 2.7M | 2.95M | 3.36M | 3.15M | 2.68M | 2.82M | 2.59M | 2.43M | 2.24M | 1.82M | 1.97M | 1.8M | 1.38M | 1.58M | 1.87M | 1.49M | 1.45M | 1.47M | 1.39M | 1.3M | 1.18M | 1.41M | 1.4M | 975.51K | 1.05M | 3.38M | 3.59M | 2.09M | 2.37M | 2.77M | 3.12M | 2.87M | 2.95M | 2.72M | 2.68M |
| Selling, General, and Administrative Revenue Growth | +20.20% | -5.89% | -17.46% | -7.02% | -15.42% | +16.61% | -8.45% | -12.39% | +6.61% | +17.83% | -5.02% | +8.59% | +6.94% | +8.51% | +22.70% | -7.26% | +9.06% | +30.77% | -12.69% | -15.79% | +26.05% | +2.38% | -1.19% | +5.77% | +7.28% | +10.24% | -16.50% | +0.28% | +43.84% | -7.33% | -68.81% | -5.91% | +71.63% | -11.96% | -14.39% | -11.06% | +8.57% | -2.78% | +8.72% | +1.34% | n/a |
| Research and Development Revenue | 2.3M | 3.31M | 2.66M | 4.91M | 3.33M | 3.8M | 6.67M | 6.04M | 5.02M | 12.98M | 4.46M | 6.8M | 5.81M | 7.12M | 10.43M | 7.34M | 5.73M | 6.64M | 6.2M | 5.55M | 2.38M | 2.37M | 1.97M | 2.51M | 1.69M | 1.66M | 1.45M | 2.22M | 1.09M | 672.58K | 280.79K | 1.29M | 4.65M | 3.18M | 7.09M | 7.52M | 9.77M | 7.16M | 7.09M | 6.68M | 5.02M |
| Research and Development Revenue Growth | -30.62% | +24.63% | -45.88% | +47.48% | -12.40% | -43.08% | +10.44% | +20.39% | -61.31% | +190.81% | -34.36% | +17.09% | -18.42% | -31.79% | +42.13% | +28.14% | -13.71% | +7.01% | +11.83% | +133.11% | +0.25% | +20.73% | -21.74% | +48.38% | +1.82% | +14.97% | -34.77% | +104.08% | +61.56% | +139.53% | -78.27% | -72.22% | +46.07% | -55.09% | -5.76% | -23.01% | +36.51% | +0.92% | +6.20% | +33.00% | n/a |